Conventus Orthopaedics says it raised a $24 million Series AA round for its implant technology, designed to treat extremities fractures in the wrist and shoulder.
Conventus Orthopaedics said it closed a Series AA round worth $24 million it plans to use to commercialize 1of its self-expanding extremities implants and advance R&D on another.
Ally Bridge Group, BioStar Ventures, Blue Sky Fund, Blue Stem Capital, Conventus Orthopaedics, Deerfield Management, Sightline Partners, Spray Fund
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1tAnQPf
Cap comentari:
Publica un comentari a l'entrada